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Several subsets of dendritic cells (DCs) are present in the oropharyngeal tonsillar tissues 
and are thought to behave as major actors in development and regulation of immunity 
by acting as a first line of recognition for airborne and alimentary antigens. We previously 
discovered in human adult tonsils infected with Epstein–Barr virus (EBV), a subset of DCs 
that expressed langerin/CD207, a lectin usually recognized as a hallmark of epidermal 
Langerhans cells (LCs). In the present study, we analyzed the content of several child 
and adult tonsils in order to characterize in more detail the phenotype of these tonsillar 
CD207-expressing DCs (tCD207 DCs) and to compare it with that of other human DC 
subsets. We showed that all the human tonsils studied (n = 12) contained significant 
proportions of tCD207 DCs among tonsillar cells expressing HLA-DR. Moreover, the 
presence of tCD207 DCs in tonsils from young children free of EBV infection indicated 
that these cells could be established early in the tonsil independently of EBV infection. 
We also showed that tCD207 DCs, that were found mainly located within the tonsillar 
lymphoid stroma, were distinguishable from LCs by the level of expression of CD1a 
and EpCAM, and also from human inflammatory DCs by the lack of CD1a, CD206, and 
CD14 expression. Detailed analysis of cell surface DC markers showed that tCD207 
DCs were unrelated to CD141+ DCs or macrophages, but defined a subtype of tonsillar 
DCs closely related to myeloid resident CD1c DCs. Since it was established that blood 
CD1c myeloid DCs exhibit plasticity and are capable of expressing CD207 notably in the 
presence of inflammatory cytokines, it is tempting to speculate that CD207+ CD1c+ DCs 
may play a specific immune role.
Keywords: tonsil, dendritic cells, antigen-presenting cells, langerin, cD207, langerhans cells, inflammatory 
dendritic cells, cD1c myeloid dendritic cells
TaBle 1 | characteristics of the study population.
Patienta age gender Tonsillectomy  
indication
tcD207  
Dcsb
cD1c  
Dcsb
cD141/clec9a  
Dcsb
pDcsb Macrophagesb eBV statusc
Child 1 1 M Tonsillar hypertrophy 1.7 7.1 3.0 84.5 2.3 Negative
Child 2 3 M Tonsillar hypertrophy 1.3 5.9 5.2 75.4 3.3 Positive
Child 3 3 M Tonsillar hypertrophy 1.5 2.8 2.5 70.7 13.3 Negative
Child 4 3 M Tonsillar hypertrophy 4.0 8.0 8.8 79.6 2.7 Negative
Child 5 3 F Recurrent tonsillitis 5.6 13.1 6.0 58.8 6.5 Positive
Child 6 4 M Tonsillar hypertrophy 0.6 3.2 2.6 88.6 1.2 Positive
Child 7 4 M Recurrent tonsillitis 1.5 4.3 2.4 85.9 0.8 Positive
Child 8 4 M Tonsillar hypertrophy 3.7 8.3 5.8 58.5 2.8 Positive
Child 9 9 F Recurrent tonsillitis 4.7 12.0 2.8 63.2 5.8 Positive
Child 10 11 F Tonsillar hypertrophy 7.5 10.7 0.8 78.1 1.5 Positive
Mean (SD) in child’s group 3.2 (2.2) 7.5 (3.6) 4.0 (2.4) 74.3 (11.1) 4.0 (3.7) N/A
Adult 11 49 M Recurrent tonsillitis 6.9 18.7 2.0 57.6 7.5 Positive
Adult 12 52 M Recurrent tonsillitis 7.8 18.1 4.9 55.8 2.3 Positive
Mean (SD) in adult’s group 7.3 (0.6) 18.4 (0.4) 3.4 (2.0) 56.7 (1.3) 4.9 (3.7) N/A
aData are provided per subject.
bFlow cytometric data are presented as % of LinnegHLA-DR+ cells gated as shown in Figure 1. Each DC population was defined as follows: tCD207 DCs are HLA-DR+ CD207+; 
CD1c DCs are HLA-DR+ CD11c+ CD1c+; CD141/Clec9A DCs are HLA-DR+ CD11c+ CD141+ Clec9A+; pDCs are HLA-DR+ CD304+; and macrophages are HLA-DR+ CD11c+ 
CD14+.
cEBV status was defined for each child by EBV serology interpretation and for adults by EBV DNA detection.
N/A, non-applicable.
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inTrODUcTiOn
The Waldeyer’s ring is a ring of lymphoid tissue that circles the 
pharynx at the entrance of the aerodigestive tract. This mucosa-
associated lymphoid tissue notably contains the palatine tonsils 
that form dense compact bodies of lymphoid tissue and the 
adenoids, tubar, and lingual tonsil. The Waldeyer’s ring grows 
throughout childhood until the age of 11  years before steadily 
declining with age (1, 2). These oropharyngeal immune tissues 
are the first organs in the lymphatic system that analyze and 
react to airborne and alimentary products with the basic func-
tion to produce antibodies to common environmental antigens. 
Dendritic cells (DCs) that colonize tonsils are thus thought to play 
a pivotal role in controlling development of immunity since these 
professional antigen-presenting cells (APCs) have the capacity to 
induce a primary immune response in naïve T lymphocytes, and 
to play a pivotal immune role in regulating innate and adaptive 
immune responses (3–5).
Usually human blood DCs have been divided into two main 
groups: plasmacytoid DCs (pDCs) and “myeloid” or “classi-
cal” DCs (cDCs). The cDCs can be further separated into two 
subsets that are usually referred to as BDCA1/CD1c+ DCs and 
BDCA3/CD141+ DCs (6), which are also found in all lymphoid 
organs and represent resident DCs (5, 7–9). Although pDCs and 
cDCs subsets have been widely characterized in human tonsils 
(3–5,  10,  11), additional tonsillar DC subsets have also been 
identified (12, 13). We previously discovered in adult human 
tonsil a new type of human DC expressing the type II trans-
membrane C-type lectin receptor langerin (CD207) (12). These 
tonsillar CD207-expressing DCs (tCD207 DCs) abundantly 
infiltrated Epstein–Barr virus (EBV)-infected areas in tonsil 
and were also commonly encountered in EBV-infected tumors 
(i.e., nasopharyngeal carcinoma and Hodgkin’s lymphoma) 
(12). Langerin/CD207 typically characterizes Langerhans cells 
(LCs) that represent migratory DCs present in the epidermis 
and form a distinct cell lineage (14–16). Interestingly, Bigley 
and co-workers (17) have recently shown that CD207 was also 
expressed on human DCs isolated from dermis, lung, liver, tonsil, 
and lymphoid tissue. These CD207-expressing DCs were shown 
to be distinguishable from conventional LCs by the expression 
level of CD1a, EpCAM, CD11b, CD11c, CD13, and CD33, and 
were proposed to be closely related to the CD1c+ DCs. Moreover, 
transcriptomic analysis has also established that CD207 can be 
expressed by human “inflammatory” DCs (infDCs), a population 
of monocyte-derived DCs with a distinct phenotype that is com-
monly encountered in inflamed tissues (18, 19). In this report, 
we set out to further characterize the tCD207 DCs we previously 
discovered in tonsils, and we found evidence of CD207 expres-
sion by CD1c+ myeloid DCs.
MaTerials anD MeThODs
human specimen collection
Palatine tonsils were collected from 10 healthy children (aged 
from 1 to 11 years old, average 4.5 years, and median 3 years) 
undergoing routine tonsillectomy (Table 1). Seven children had 
surgery for tonsillar hypertrophy inducing obstructive sleep 
apnea syndrome and three for recurrent tonsillitis. In addition, 
tonsils from two healthy adults were also collected for recurrent 
tonsillitis. Tonsils were directly obtained at the operating room 
of the pediatric and adult otorhinolaryngology departments of 
Nice hospitals and processed extemporaneously for cell dissocia-
tion. This study was carried out with approval from the national 
ethical committee, “Comité de Protection des Personnes” depart-
ment “Sud-Méditerranée V,” with written informed consent from 
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all donors or parental donors for children. All subjects gave 
written informed consent in accordance with the Declaration of 
Helsinki.
Tonsillar cell isolation and Flow 
cytometric analysis
Release of mononuclear cells from tonsil stroma was performed 
as previously described (3). The tonsils were kept in RPMI 
1640 medium (Gibco®), then cut into small fragments, and 
incubated for 30 min with constant stirring in the presence of 
dissociation enzymes [Liberase TL (Roche) 0.1 mg/ml, DNase 
(Roche) 0.1 mg/ml]. Mechanical dissociation of tissues was also 
achieved with the gentleMACS™ dissociator (Miltenyi Biotec) 
used before and after enzyme digestion. After filtration through 
a 40-μM filter (cell strainers, BD Biosciences), tonsillar mono-
nuclear cells were collected by density gradient centrifugation 
(Lymhocytes Separation Medium, Eurobio) and depleted of T 
cells and B cells by immunomagnetic selection (CD3 and CD19 
microbeads, Miltenyi Biotec). DC-enriched samples were then 
stained with fluorochrome-conjugated mouse monoclonal 
antibodies for the detection of cell surface markers as fol-
lows: HLA-DR BV605 (BioLegend), CD3 FITC or APC (BD 
Biosciences), CD19 FITC or PE (BD Biosciences), CD56 FITC 
(BD Biosciences), CD207 PE-Vio770 or APC-Vio770 (Miltenyi 
Biotec), CD1a PerCp-Cy5.5 (BioLegend), CD11c APC (eBio-
science), CD141 APC-Vio770 (Miltenyi Biotec), Clec9A PE 
(BioLegend), CD1c APC or PE-Cy7 (eBioscience), CD14 PE or 
FITC (eBioscience), CD206 APC (BD Biosciences), FcERI PE 
(BioLegend), CD304 APC (Miltenyi Biotec), and CD45 PE-Cy7 
(BD Biosciences). Non-specific fixation of antibodies to human 
Fc receptors was blocked (Human Fc Receptor TruStain FCX™ 
Blocking Solution, BioLegend). Non-viable cells were excluded 
by DAPI staining (BD Biosciences). Fluorescence-minus-one 
(FMO) controls were performed to define background fluores-
cence for each marker. Multiparameter fluorescence-activated 
cell sorting (FACS) analysis was performed using a FACS 
Canto II (BD Biosciences), and data were analyzed with FlowJo 
software.
eBV infection status
Epstein–Barr virus infection status was defined by serology for 
children. Serological tests for antibodies specific for EBV antigens 
were used to define infection status [viral capsid antigen (VCA) 
IgG, VCA IgM, and EBV nuclear antigen (EBNA) IgG] (Liaison 
analyzer, Diasorin). The presence of VCA IgG and VCA IgM, or 
VCA IgG and EBNA IgG indicated positive infection, and the 
absence of VCA IgG, EBNA IgG, and VCA IgM characterized 
uninfected children. For the two adults, the EBV infection status 
was defined by the EBV DNA detection in tonsils using standard 
PCR (EBV R-gene, Argène, BioMérieux).
immunohistochemical studies
Fragments from each tonsil were fixed in formalin, embedded 
in paraffin, and processed for histological analyses. Five-micron 
sections of formalin-fixed paraffin-embedded tissues were 
 deparaffinized, rehydrated, and stained with hematoxylin and 
eosin (H&E). Tissue sections were treated for heat-induced 
epitope retrieval using a pre-heated solution EDTA pH 9 at 97°C, 
and then non-specific staining was blocked with peroxidase-
blocking reagent (EnVision™ FLEX Peroxidase-Blocking 
Reagent, Dako) and incubated with CD207 mouse monoclonal 
antibody (Bio SB) diluted 1:50 in antibody diluent (EnVision™ 
FLEX Antibody Diluent, K8006, Dako). Immunohistochemical 
studies (IHC) were performed using the EnVision™ FLEX Mini 
Kit detection system (K8023, Dako).
statistical analysis
Statistical analysis was carried out with Easy Med Stat© 
(www.easy-med-stat.com). When evaluating differences in con-
tinued variables between two unpaired small groups, the Mann–
Whitney U test was performed. When an association between 
two small groups was researched, the Fisher test was used, and 
correlation coefficients were calculated using Spearman’s rank 
method. p values of <0.05 were considered significant.
resUlTs
consistent Presence of langerin/ 
cD207-expressing Dcs in human Tonsils
This study was focused on tonsils from 10 children and from 
2 adults as summarized in Table  1. The DC-enriched tonsil-
lar fractions from all tonsils were analyzed by FACS gated on 
lineage negative (Linneg: CD19−CD3−CD56−) mononuclear cells 
expressing HLA-DR (Linneg HLA-DR+) (Figure 1A). Accordingly 
to previous work (5), different subsets of HLA-DR+ DCs were 
identified within tonsils (Figures 1B–E). The pDCs (HLA-DR+ 
CD304+) (Figure  1C) were the most abundant tonsillar DCs 
with a frequency ranging around 74.3% (±11.1) of the tonsillar 
HLA-DR+ cells in the child group (n = 10) and 56.7% (±1.3) in 
adults (n = 2) (Table 1). Classical myeloid DC subsets, such as 
CD1c DCs (Figure 1E), CD141/Clec9A DCs (Figure 1D), and 
macrophages (Figure 1E), were also consistently detected and 
represented around 7.5% (±3.6), 4.0% (±2.4), and 4.0% (±3.7), 
respectively, in the child group (n =  10) and 18.4 (±0.4), 3.4 
(±2.0), and 4.9 (±3.7), respectively, in adults (n = 2). Moreover, 
all tonsils also contained CD207-expressing HLA-DR+ cells 
(tCD207 DCs) (Figure 1F) with an average frequency of 3.2% 
(±2.2) in children and 7.3% (±0.6) in adults (Table 1). Variable 
levels (0.6–7.5%) of tCD207 DCs were found among the child 
tonsils studied but intriguingly, the oldest child (child 10 and 
11 years) had the highest level of tCD207 DCs (7.5%), similar to 
the level found for the two adult tonsils (6.9 and 7.8%) analyzed 
(Table 1). As shown in Table 1, independently of the EBV infec-
tion status, tCD207 DCs were always detected in tonsils and 
we did not find any correlation between tCD207 DC frequency 
and EBV infection status. Their consistent presence in child and 
adult tonsils suggests that tCD207DCs may play an important 
role in immune functioning of the oropharyngeal lymphoid 
tissues.
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tcD207 Dcs are Distinct from lcs and 
infDcs and represent a subset of 
resident cD1c+ Dcs
Localization of tCD207 DCs in tonsils was investigated by IHC 
analysis performed on tissue sections (Figures  2A–F). The 
tCD207 DCs showed a typical DC morphology (Figure  2F) 
and were mainly detected outside germinal centers (GC) 
within the tonsillar lymphoid stroma (Figures 2A,B) but were 
also detected in tonsil epithelium (Figures  2C,D). Random 
counting of tCD207 DCs in tissue sections indicated a rather 
good correlation with the tCD207 DC frequency measured 
by FACS. We first investigated the possibility that tCD207 
DCs may share some phenotypes with conventional LCs. 
FACS analysis of usual markers of conventional LCs such 
as CD11c, CD1a, and the epithelial cell adhesion molecule 
(EpCAM) revealed that while most tCD207 DCs expressed 
CD11c (median 97.3%), only a few tCD207 DCs expressed 
CD1a (median 16.5%), and no tCD207 DCs were found to 
express EpCAM (median 0.2%) (Figures 3A,C). Taking into 
account the atypical location of tCD207 DCs in tonsillar 
lymphoid stroma and the lack of expression of major mark-
ers of the LC lineage, we concluded that tCD207 DCs were 
clearly distinguishable from conventional LCs. Whether or 
not the few tCD207 DCs located within the tonsil epithelium 
represent true tonsillar LCs may require further investigation. 
Second, we also excluded the possibility that tCD207 DCs, 
which were initially described in viral inflammatory condition 
(12), may be related to human infDCs (18, 19) since major 
hallmarks of infDCs were detected only at a low frequency on 
tCD207 DCs (Figure 3), notably CD1a (median 16.5%), CD14 
(median 9.6%), and CD206 (median 10.2%). Further analysis 
of cell surface expression of several DC markers (Figure  3) 
also showed that a high proportion of tCD207 DCs expressed 
CD1c (median 71%), but in contrast these DCs appeared dis-
tinct from others DC subsets like pDCs (HLA-DR+ CD304+), 
CD141/Clec9A DCs and CD14+ macrophages. Of note, a 
variable proportion of tCD207 DCs were found to express 
FcERI (median 49.2%), and a smaller proportion of these cells 
expressed CD141 (median 28.1%).
Last, we considered the expression level [mean fluorescence 
intensity (MFI)] of each DC marker to further characterize 
tCD207 DCs in comparison with other tonsillar DC subsets 
(Figure  4). The MFI of CD207 was significantly higher in 
tCD207 DCs compared with all other tonsillar HLA-DR+ cells. 
Interestingly, CD1c DCs and tCD207 DCs appeared to be closely 
related since, apart from CD207, no other significant difference 
was measured regarding levels of expression of typical CD1c 
DC markers. In particular, CD11c expression was high and 
CD1c was expressed at a similar level in both subsets while the 
expression of Clec9A was null (Figure 4A). In contrast, tCD207 
DCs clearly differed from all other tonsillar DC subsets, namely, 
CD141/Clec9A DCs (Figure  4B), pDCs (Figure  4C), and 
macrophages (Figure 4D), since tCD207 DCs did not express 
most of the DC markers that constitute their conventional 
FigUre 1 | identification of different Dc subsets in tonsils. 
Representative gating strategy to define the main tonsillar DC subsets.  
(a) Gating strategy to identify viable Linneg HLA-DR+ tonsillar mononuclear 
cells. (B,c) The panels represent tonsil mononuclear cells gated as Linneg and 
analyzed for HLA-DR, CD11c, and CD304. (D,e) The panels show gated 
Linneg HLA-DR+ CD11c+ cells (red arrows) analyzed for expression of CD141, 
clec9A, CD1c, and CD14. The main tonsillar subsets are indicated. (F) Plot 
represents gated Linneg cells analyzed for expression of HLA-DR and CD207. 
These data are representative of 12 independent experiments (10 children 
and 2 adults).
FigUre 2 | tcD207 Dcs are located in tonsillar lymphoid stroma. (a,c) H&E and (B,D) CD207 immunohistochemical staining (brown) of a tonsillar  
paraffin-embedded tissue sections (low magnification 10×). These analyses were performed on 10 children tonsillar paraffin-embedded tissue sections and 2 
adults. The tCD207 DCs are located (a,B) outside the germinatif centers (GC) and (c,D) in the epithelium. (e,F) Characteristic DC morphology, high magnification of 
CD207 immunohistochemical staining, 50× (e) and 100× (F).
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hallmarks. Collectively, these results showed that tCD207 DCs 
were probably not related to LCs, infDCs, CD141/Clec94 DCs, 
or monocytes/macrophages, but likely linked to the CD1c 
myeloid DC lineage through the expression of CD11c and CD1c 
and variable expression of FcERI and CD141. Moreover, the link 
between tCD207 DCs and CD1c DCs tonsillar population was 
also strengthened by the fact that the abundance of tCD207 DCs 
and CD1c DCs in each tonsil showed a strong positive linear 
correlation (SC = +0.897, p < 0.05, n = 12) (Figure 4E), while 
no significant correlation could be measured with all the other 
DC subsets (not shown).
DiscUssiOn
This work follows up our previous work (12) describing for 
the first time a subpopulation of human DCs in adult tonsils 
with expression of CD207 while not being classical LCs. Better 
characterization of subpopulations of human DCs is timely and 
important since this cell type is a potential target for cell-based 
immunotherapy. We aimed here to present a detailed phenotypic 
characterization for defining the cell surface phenotype of the 
langerin/CD207-expressing DCs encountered in human tonsils 
human. Our results show that all human tonsils are consistently 
FigUre 3 | Phenotypic characterization of tcD207 Dcs.  (Continued)
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FigUre 4 | comparative analysis of levels of expression of different Dc markers on tcD207 and other Dc subsets. (a–D) Graphs show the expression 
levels (MFI) of different indicated DC markers on tCD207 DCs (linnegHLA-DR+CD207+) compared to (a) CD1c DCs (HLADR+CD11c+CD1c+), (B) CD141 DCs 
(HLADR+CD11c+CD141+Clec9A+), (c) pDCs (HLADR+CD304+), or (D) macrophages (HLADR+CD11c+CD14+). (a–D) Data are expressed as mean MFI values ± SD 
for 12 independent tonsil samples (10 children and 2 adults). p value comparing two groups (Mann–Whitney U test): *p < 0.05; **p < 0.01; ns: not significant. (e) 
Correlation between frequencies (%) of tCD207 DCs and CD1c DCs in 12 independent tonsils (10 children and 2 adults). Correlation coefficient of Spearman (SC) 
and p value are shown.
(a) Dotplots represent tonsil mononuclear cells gated as linneg and analyzed for expression of HLA-DR, CD207, CD11c, CD1a, EpCAM, CD141, Clec9A, CD1c, 
CD14, and CD304. This analysis is representative of 12 independent experiments (10 children and 2 adults). (B) Dotplots represent tCD207 DCs gated as shown in 
(a) (linnegHLA-DR+CD207+ cells) and analyzed for expression of CD1c, CD206, FcERI, and CD1a. (c) The graph shows the percent (%) of tCD207 DCs  
(linnegHLA-DR+CD207+ cells) expressing CD11c, CD1c, FcERI, CD141, CD1a, CD304, CD206, CD14, Clec9A, and EpCAM. The medians of 12 independent 
experiments are represented by columns. All experiments are shown in distinct symbols.
FigUre 3 | continued
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infiltrated with significant amount of tCD207 DCs that may rep-
resent around 3.2 and 7.3% of the total content of the HLA-DR+ 
tonsillar DCs in child and adult tonsils, respectively. Interestingly, 
these tCD207 DCs are also shown to be closely related to the 
myeloid CD1c DC lineage.
It was first tempting to speculate that the tCD207 DCs, which 
were initially discovered in an inflammatory viral environment 
(12), might share some properties with the human infDCs. 
Indeed, infDCs found in human inflammatory fluids, also have 
a relatively high level of CD207 gene expression compared to 
inflammatory macrophages (NCBI, Gene Expression Omnibus, 
Query DataSets for GSE40484). Although tCD207 DCs and 
infDCs have several conventional markers of the myeloid DC line-
age (CD11c, CD1c, and FcERI) in common, we however exclude 
the possibility that tCD207 DCs could be related to infDCs since 
tCD207 DCs do not express CD1a, CD14, and CD206 which 
are consistent hallmarks of infDCS (18). Second, the CD207 
marker was long believed to be exclusively expressed by LCs, 
which represent a distinct lineage from pDCs and cDCs (7), and 
represent major APCs within the epidermis and stratified epithe-
lium of bronchi and mucosae (14, 15, 20–23). LCs are identified 
based on the expression of HLA-DR, CD207 but also high level 
of CD1a and EpCAM (15). The lack of hallmarks of the LC line-
age (CD1a and EpCAM) coupled with the unusual location of 
CD207 DCs in tonsillar lymphoid stroma led us to conclude that 
tCD207 DCs are different from conventional epidermal LCs. In 
mouse, elegant works have established that dermal CD207+ DCs 
and LCs can represent distinct lineages (24–26). It was notably 
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shown that the mouse dermis contains a population of CD207+ 
DCs, termed dermal CD207+ DCs, that develop independently 
of epidermal LC population (24–26). In human, the existence 
of CD207+ DCs unrelated to LCs has been proposed but is yet 
poorly described. The CD207 expression has been reported in 
the lamina propria of patients suffering of inflammatory bowel 
diseases (27) or celiac disease (28), in kidneys (29), or in breast 
cancer (30), but it remains to be determined whether these cells 
are related to LCs or not. Moreover, Bigley et al. (17) have recently 
reported the existence of human CD207+ DCs widely distributed 
and closely related to CD1c DCs but clearly distinguishable from 
LCs. In that study, CD1a+CD1c+CD207+ DCs were found in 
human dermis, while in lung, liver, and tonsil, CD1c+ DCs were 
shown to also express CD207 with a variable CD1a expression 
(17). Strikingly, the CD1c+CD207+ DCs described by Bigley and 
co-workers (17) display a very similar profile to the tCD207 
DCs we described here, with a high level expression of CD11c 
and CD1c, and the lack of characteristic markers of CD141 DCs 
such as Clec9A (17). Moreover, we show here that tCD207 DCs 
in children and adults are present in lymphoid stroma and not 
only in tonsil epithelium but also these cells are also related to 
CD1c DCs with variable FcERI and intermediate CD141 expres-
sion. In addition, we observed a significant correlation in the 
abundance of tCD207 DCs and CD1c DCs in tonsil, suggesting a 
direct relationship between these two types of DCs. Collectively, 
these observations thus strongly suggest that the tCD207 DCs 
we describe here are likely closely related to CD1c resident DCs 
and may belong to this DC subset. Since it was established that 
CD1c myeloid DCs exhibit plasticity and are capable of express-
ing CD207 notably in the presence of inflammatory cytokines 
like TGFβ (17, 31,  32), an attractive hypothesis could be that 
some resident tonsillar CD1c DCs may express CD207 under 
local inflammatory conditions. One caveat of our experiments is 
that all tonsils used in this study were from patients with chronic 
tonsillitis or tonsillar hypertrophy. The fact that these pathologi-
cal conditions may be responsible for CD207 expression in CD1c 
DCs is an interesting question. Notably it would be interesting 
to determine whether the tCD207 DC population shares similar 
gene expression signatures and functional properties with the 
CD1c DC subset. In particular, CD1c DCs are competent to 
activate CD4 T cells and can induce Th1 or Th17 polarization but 
are poor inducers of Th2 responses (7). Whether tCD207+CD1c+ 
DCs play a similar role, or may likely play specific activities that 
differ from conventional CD1c DCs will be investigated.
The selective expression of pattern recognition receptors, 
including lectins and TLRs, confers specialized functions to 
different populations of DCs. Langerin/CD207 is known to 
bind pathogens like mycobacteria (33), fungi species (34), 
viruses such as HIV (35), influenza (36), or HSV (37), but the 
function of CD207 in antigen uptake is still unclear. The role 
of DCs expressing CD207 as inducers of immunity (38–40), 
as tolerogenic modulators (28, 41–43) or as antigen transport-
ers between different DCs  (44), is debated. Interestingly, we 
previously discovered tCD207 DCs in adult tonsils infected with 
EBV and showed that these cells were geographically grouped in 
close contact with tonsillar EBV-infected cells suggesting a pos-
sible link between EBV infection and tonsillar DC infiltration. 
To further investigate a possible link between EBV infection 
and tCD207 DC, we focused here on the analysis of tonsils col-
lected from children known to be infected or naïve regarding 
EBV infection. Indeed, EBV infection is highly prevalent in the 
human adult population (95%) and usually occurs early during 
infancy (45). Using tonsils from young children, we were here 
able to demonstrate that tCD207 DCs were present in tonsils 
independently of the individual’s EBV status. This result indi-
cates that tCD207 DCs are present in tonsils even before EBV-
infection. Although this result may appear to be contradictory 
with our previous observations achieved in adult tonsils, it must 
be pointed out that adult and child tonsils may differ greatly, 
not only regarding tonsil structure and immune functions, but 
also concerning local inflammatory conditions associated with 
long-term recurrent tonsillitis. One hypothesis could be that 
long-term chronic EBV replication in adult tonsils may worsen 
local inflammation and may favor the persistence of tCD207 
DCs, mainly in EBV-infected clusters (12). In this context, the 
higher tCD207 DC frequency observed in EBV-infected adult 
tonsils may strengthen this hypothesis. Previously, we also 
found abundant CD207-expressing DCs in EBV-associated 
malignancies (12). Whether these CD207-expressing DCs 
found in EBV-associated tumors are similar to tCD207 DCs 
and what role these DCs may play in tumor biology is of great 
interest and remains to be further investigated.
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